Compare HairGenesis® to Finasteride/Propecia® Review

For men and women concerned about pattern hair loss, it is important to buy the best hair loss treatment product available. Here, we compare HairGenesis® to the drug finasteride, sold under the tradename Propecia®.

Finasteride/Propecia®

What is Finasteride/Propecia

One of the better-known hair growth drugs, orally administered Propecia®, is based on the drug finasteride 1mg. Finasteride, a potent antagonist of the steroid hormone enzyme 5 alpha-reductase type II, was originally created to treat benign prostatic hyperplasia (BPH). The precise biochemical mechanism by which finasteride operates is known to be competitive inhibition of the type II isoform of the enzyme 5 alpha reductase. Finasteride for BPH is dispensed in 5mg. form under the trade name Proscar®.

What Finasteride/Propecia Costs

A one-month prescription for Propecia® runs approximately $100. The cost of medical supervision is variable and often based on the patient's medical insurance status.

What is Claimed

Finasteride 1mg. (Propecia®) is deployed to treat male pattern hair loss in men but is not indicated for use by women.

Where's the Proof?

Finasteride 1mg. (Propecia®) is supported with well-controlled clinical studies which report positive changes in treated subjects, as quantified by changes in hair caliber and gross visible density.

What Can Go Wrong

According to the literature, due to the potential for feminizing birth defects finasteride is absolutely not indicated for hair use by women. Moreover, it is advised that women avoid handling either the tablets or crushed powder due to the same contra-indications. In the male only patient population for whom finasteride is indicated, other negative side effects are reported. These include loss of libido, changes rendering PSA unreliable, reduced ejaculate volume, and other negative side effects.

Why HairGenesis® May Represent a Better Alternative

Unlike finasteride which has activity primarily against type-2 5 alpha-reductase, HairGenesis® contains highly potent but naturally derived inhibitors of both type-1 and type-2 5 alpha-reductase. Furthermore, in contrast to all drug-based hair loss treatments, HairGenesis® has never been linked to negative side effects of any kind. Unlike the non-drug based hair loss products, HairGenesis® has been proven safe and highly effective under IRB-monitored, placebo-controlled, double-blind clinical research, as well as university-based formal research, now demonstrating a dual-mechanism of action against inflammation in the hair follicle and pathologic DHT. HairGenesis® is the only non-drug hair loss treatment formula supported with proven research published in the peer-reviewed medical and scientific literature (pubmed.com).

		Finasteride/ Propecia
Active composition 100% natural botanically-derived product?
A dual proprietary composition shown via published medical research to block both 5 alpha-reductase-- enzyme trigger of DHT metabolism as well as pathologic inflammation of the hair follicle?
Available without a prescription?
Entire Treatment Regimen free from known potential negative side effects?
Minoxidil-Free Hair Loss Product?
Maximum Strength Product Suitable And Available For Both Men And Women?
Peer-reviewed Clinical Evidence shows benefit in treating frontal hair loss?
Proprietary composition successfully tested in IRB-Monitored, placebo-controlled, double blind research?
Clinical Results from proprietary composition published in peer-reviewed medical literature?

The above information was derived from publicly available data at the time the information was compiled, and is not intended to verify or dissuade any claims for any product other than HairGenesis™. The compositions of competing hair restoration products, and representations made by competitors about their respective products are subject to change. This web site is not responsible for the compositions or representations made by competing hair restoration products, or any errors or omissions that may occur as a result. At the present time, January 2009, no non-pharmaceutically derived hair loss treatment is technically required by the FDA to undergo placebo-controlled, double-blind clinical research. Nor is such research required to be submitted for validation and publication by and within the peer-reviewed medical literature. HairGenesis™ has undertaken these difficult, costly and time-intensive steps in the interest of demonstrating, for the benefit of consumers, its safety and efficacy under the most scientifically objective and stringent conditions. Among the non-drug based hair loss treatments, in successfully achieving these milestones, HairGenesis™ stands alone. Product Names are the trademarks of the companies represented by those products.